Navigation Links
Boston Scientific Welcomes FDA Panel Recommendation to Approve PROMUS(TM) / XIENCE(TM) V Everolimus-eluting Coronary Stent System
Date:11/29/2007

NATICK, Mass., Nov. 29 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today welcomed the recommendation of a U.S. Food and Drug Administration (FDA) advisory panel to approve with conditions the PROMUS(TM) / XIENCE(TM) V everolimus-eluting coronary stent system. The PROMUS and XIENCE V stent systems are identical products, sold respectively by Boston Scientific and Abbott in international markets. Both stent systems would be covered by the same FDA approval.

"Today's recommendation is a significant step toward making Boston Scientific's two-drug program a reality in the United States," said Hank Kucheman, Senior Vice President and President of Boston Scientific's Cardiovascular business. "Once approved in the United States, the PROMUS stent system -- together with our proven and market-leading TAXUS stent technology -- will enable Boston Scientific to offer physicians and their patients a choice of two distinct drugs, each on a highly deliverable stent platform."

The PROMUS and XIENCE V stent systems are investigational devices in the U.S. and not yet approved for sale. PROMUS is a private-labeled XIENCE V everolimus-eluting stent system manufactured by Abbott and distributed by Boston Scientific.

TAXUS and PROMUS are trademarks of Boston Scientific Corporation or its affiliates. XIENCE is a trademark of the Abbott Laboratories group of companies.

Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical specialties. For more information, please visit: http://www.bostonscientific.com.

Cautionary Statement Reg
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Boston Micromachines Multi-DM Named One of the Years Most Innovative Products
2. Boston University School of Medicine researcher recipient of Memory Ride Grant
3. Success of Shape-Up Somerville Childhood Obesity Intervention to be Presented at the Friedman School Symposium at Tufts, October 29-31, 2007 - Boston
4. AAHFNs 2008 Annual Meeting in Boston Will Be Raising the Bar in Heart Failure Care
5. Families Invited to Celebrate Shire Day at Boston Childrens Museum
6. Boston Scientific Announces Amended Agreement to Settle Product Lawsuits
7. Boston Scientific Announces New Initiatives to Increase Shareholder Value
8. Boston Scientific Announces Additions to Clinical Sciences Organization
9. Boston University School of Medicine physician receives award from AATOD
10. Boston Scientific Announces Verdict in Cordis Litigation
11. Boston Scientific Announces Sale of Cardiac Surgery and Vascular Surgery Businesses
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... Legislation passed today by the House ... to help prevent inappropriate prescriptions in Medicare Part ... the Integrity of Medicare Act (PIMA), introduced by ... (R-TX) and Ranking Member Jim McDermott (D-WA), recognizes ... epidemic and implement the right policies, said the ...
(Date:2/27/2015)... Dawn Greene Hospice, a 10-bed facility located on the 15th ... East Side, was officially dedicated and blessed at a ceremony ... Cardinal Dolan. , Thomas J. Fahey, Jr., MD, chairman of ... the ArchCare Board of Trustees, presided over the event with ... MMW, and Christina McInerney, president and CEO of The Jerome ...
(Date:2/27/2015)... February 27, 2015 Mediaplanet today announces ... Health,” a campaign that aims to bring blood health ... care conversation. The stories in this edition go beyond ... of clinical care, hard-hitting advocacy, research and technological strides ... According the American Cancer Society, approximately every 3 ...
(Date:2/27/2015)... Healthpointe is now performing arthroscopy ... or diseases affecting the elbow , wrist ... throughout Southern California, and are dedicated in providing ... related to the upper extremities. , Dr. ... board-certified and fully trained in treating an array ...
(Date:2/27/2015)... 27, 2015 Dr. Christopher Saunders, a ... Special at his Chadds Ford, Pa., location. The spring ... 2015, and will be priced at $3,950 with all ... implants, it will include more than $3,000 in MedSpa ... of free Dysport. , Space is very limited, so ...
Breaking Medicine News(10 mins):Health News:PCMA Statement on the ‘Protecting the Integrity of Medicare Act’ 2Health News:The Dawn Greene Hospice Is Officially Dedicated 2Health News:The Dawn Greene Hospice Is Officially Dedicated 3Health News:Know Your Blood: Raising Awareness through Mediaplanet’s “Blood Health” Campaign 2Health News:Healthpointe is Now Performing Arthroscopic Surgery Techniques for Elbow, Hand and Wrist Injuries and Diseases, such as certain Ganglion Cysts 2Health News:Dr. Christopher Saunders Announces Spring Breast Augmentation Special at $3,950 2Health News:Dr. Christopher Saunders Announces Spring Breast Augmentation Special at $3,950 3
... ... Single Sign On Manager to allow complete its Identity Management Suite. Software allows for ... , ... 24, 2010 -- With the release of Enterprise Single Sign On Manager (E-SSO-M), Tools4ever ...
... ... Branding & Website , ... Stafford, VA (PRWeb) February 23, 2010 -- FlexRN, a nurse staffing agency ... and the launch of its new website at www.flexRN.com . The efforts ...
... others , WEDNESDAY, Feb. 24 (HealthDay News) -- ... by the experience, an English study finds. , University ... 270 students, and found little difference between students of ... male students actually had higher productivity following their parents, ...
... ... Mexico from Honeymooners to Business travelers to Spring Break Vacations , ... (PRWEB) -- When in Mexico for spring break, family ... an unforeseen emergency. AssistCare Mexico , a concierge-style health and security service with operations ...
... ... ... , ... , ...
... UK ... magnesium products, including magnesium oil, magnesium gel, and magnesium bath flakes. ... San Ramon, CA ... www.GoodHealthNaturally.com as the exclusive UK distributor of its Ancient Minerals topical magnesium supplements, ...
Cached Medicine News:Health News:Enterprise SSO Manager From Tools4ever Revolutionizes Identity and Access Management 2Health News:Nurse Staffing Agency, FlexRN, Unveils New Corporate Branding & Website 2Health News:Just in Time for Spring Break 2010, AssistCard Mexico Launches Concierge-style Health and Security Services for Travelers to Mexico 2Health News:Just in Time for Spring Break 2010, AssistCard Mexico Launches Concierge-style Health and Security Services for Travelers to Mexico 3Health News:Just in Time for Spring Break 2010, AssistCard Mexico Launches Concierge-style Health and Security Services for Travelers to Mexico 4Health News:Northern Illinois Proton Center on the Verge of Major Medical Breakthrough 2Health News:Northern Illinois Proton Center on the Verge of Major Medical Breakthrough 3Health News:Northern Illinois Proton Center on the Verge of Major Medical Breakthrough 4Health News:Northern Illinois Proton Center on the Verge of Major Medical Breakthrough 5Health News:Northern Illinois Proton Center on the Verge of Major Medical Breakthrough 6Health News:Northern Illinois Proton Center on the Verge of Major Medical Breakthrough 7Health News:Northern Illinois Proton Center on the Verge of Major Medical Breakthrough 8Health News:Ancient Minerals Topical Magnesium Oil Now Available in the UK 2Health News:Ancient Minerals Topical Magnesium Oil Now Available in the UK 3
(Date:2/27/2015)... , Feb. 27, 2015  Bionik Laboratories Corp. (OTC:DWTPD), ... announced today that it acquired Bionik Laboratories, Inc., a ... completed the sale to qualified accredited investors of units ... gross proceeds of approximately $6.2 million. Shares of the ... the OTC Markets under the symbol "DWTPD" until FINRA,s ...
(Date:2/26/2015)... DALLAS , February 27, 2015 ... Review, H2 2014 market research report to its ... the Corneal Ulcers, therapeutic pipeline. The ... information on the therapeutic development for Corneal Ulcers. ... infections that includes bacterial infections, viral infections & ...
(Date:2/26/2015)... MOUNTAIN VIEW, Calif. , Feb. 26, 2015  IRIDEX ... will release its fourth quarter and full year 2014 financial ... 2015.   In conjunction with the release, the Company will ... 5:00 p.m. Eastern Time on Thursday, March 5, ... other business developments. Interested parties may access the ...
Breaking Medicine Technology:Bionik Laboratories Raises $6.2 Million 2Bionik Laboratories Raises $6.2 Million 3Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 2Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 3Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 4Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 5IRIDEX Announces Fourth Quarter and Full Year 2014 Conference Call and Release Date 2
... - Cobalis Corp.,(OTCBB:CLSC), a pharmaceutical development company ... from two Phase III clinical trials for ... moderately severe,seasonal allergic rhinitis, commonly known as ... levels in both placebo and,PreHistin-treated patient groups, ...
... cell lung cancer -, LOS ANGELES, July 09, ... positive Phase III clinical,data published in the July ... that low expression of the biomarker,Excision-Repair Cross-Complementing 1 ... cancer (NSCLC) predicts for,sensitivity to cisplatin-based chemotherapy. ERCC-1 ...
Cached Medicine Technology:Cobalis Reports Phase III Trial Results for PreHistin in Seasonal,Allergic Rhinitis 2Cobalis Reports Phase III Trial Results for PreHistin in Seasonal,Allergic Rhinitis 3Cobalis Reports Phase III Trial Results for PreHistin in Seasonal,Allergic Rhinitis 4Cobalis Reports Phase III Trial Results for PreHistin in Seasonal,Allergic Rhinitis 5Response Genetics Announces Publication of a Phase III Clinical,Trial Demonstrating That Low Levels of ERCC-1 Help to Predict,Likelihood of Response to Cisplatin-Based Therapy in Lung Cancer 2Response Genetics Announces Publication of a Phase III Clinical,Trial Demonstrating That Low Levels of ERCC-1 Help to Predict,Likelihood of Response to Cisplatin-Based Therapy in Lung Cancer 3Response Genetics Announces Publication of a Phase III Clinical,Trial Demonstrating That Low Levels of ERCC-1 Help to Predict,Likelihood of Response to Cisplatin-Based Therapy in Lung Cancer 4
Quick Release buckle apron is user friendly with large support straps crisscrossing the back allowing proper placement of the belt at your waist....
... Our unique velcro design ... for additional support and comfort. ... two velcro flaps aid in ... A comfortable fit is attained ...
This one of a kind design also provides full body protection. Split down each side, like a poncho, this apron is simple to put on and take off. Available with an orthopedic wide belt or buckle belt....
Gonad shields protect the reproductive organs. Available in male and female models. One size fits all....
Medicine Products: